FrancophonIA/ELRC3.0 huggingface dataset:
English: - In cycles 1 to 4, Bortezomib SUN is administered twice weekly on days 1, 4, 8, 11, 22, 25, 29
Danish: - I cyklus 1 til 4 gives Bortezomib SUN to gange om ugen på dag 1, 4, 8, 11, 22, 25, 29 og 32.
English: breathing that becomes shallow, difficult or stops, wheezing - hiccups, speech disorders - increased or decreased urine production (due to kidney damage), painful passing of urine or blood/proteins in the urine, fluid retention - altered levels of consciousness, confusion, memory impairment or loss - hypersensitivity - hearing loss, deafness or ringing in the ears, ear discomfort - hormone abnormality which may affect salt and water absorption - overactive thyroid gland - inability to produce enough insulin or resistance to normal levels of insulin - irritated or inflamed eyes, excessively wet eyes, painful eyes, dry eyes, eye infections, lump in the eyelid (chalazion), red and swollen eyelids, discharge from the eyes, abnormal vision,
Danish: Nogle af disse sygdomme indebærer vejrtrækningsbesvær, kortåndethed, kortåndethed uden fysiske udfoldelser, overfladisk eller besværet vejrtrækning eller stop i vejrtrækningen, hvæsende vejrtrækning - hikke, taleforstyrrelser - øget eller nedsat urinproduktion (pga. nyreskade), smerter ved vandladning og blod/protein i urinen, væskeophobning - forandringer i bevidsthedsniveau, forvirring, nedsat eller tab af hukommelse - overfølsomhed - tab af hørelse, døvhed eller ringen for ørene, ubehag i ørerne - hormonelle uregelmæssigheder, som kan påvirke salt- og vandoptagelsen - overaktiv skjoldbruskkirtel - manglende evne til at danne tilstrækkeligt insulin eller resistens mod normale insulinniveauer - irriterede eller betændte øjne, meget våde øjne, smerter i øjnene, tørre øjne, øjeninfektioner,
English: Mediana (95% CI)
Danish: Hazard-ratiob (95 % CI)
English: Dexamethasone is administered orally at 40 mg on days 1, 2, 3, 4, 8, 9, 10 and 11 of the Bortezomib SUN treatment cycle.
Danish: Dexamethason administreres oralt ved en dosis på 40 mg på dag 1, 2, 3, 4, 8, 9, 10 og 11 i Bortezomib SUN-behandlingscyklussen.
English: Then, Bortezomib SUN may be reinitiated with one dose level reduction (from 1.3 mg/m2 to 1 mg/m2, or from 1 mg/m2 to 0.7 mg/m2).
Danish: Bortezomib SUN kan så genoptages med et reduceret dosisniveau (fra 1,3 mg/m2 til 1 mg/m2 eller fra 1 mg/m2 til 0,7 mg/m2).
English: Respiratory failure, Acute respiratory distress syndrome, Apnoea, Pneumothorax, Atelectasis, Pulmonary hypertension, Haemoptysis, Hyperventilation, Orthopnoea, Pneumonitis, Respiratory alkalosis, Tachypnoea, Pulmonary fibrosis, Bronchial disorder*, Hypocapnia*, Interstitial lung disease, Lung infiltration, Throat tightness, Dry throat, Increased upper airway secretion, Throat irritation, Upper-airway cough syndrome
Danish: akut), pulmonal alveolær hæmoragi#, bronkospasme, KOL*, hypoksæmi*, luftvejskongestion*, hypoksi, pleuritis*, hikke, rinorré, dysfoni, hvæsende vejrtrækning Sjælden Respirationssvigt, akut respiratory distress syndrome, apnø, pneumothorax, atelektase, pulmonal hypertension, hæmoptysis, hyperventilation, ortopnø, pneumonitis, respiratorisk baseosis, takypnø, lungefibrose, bronkiesygdom*, hypokapni*, interstitiel lungesygdom, lungeinfiltration, sammensnøring af halsen, tør i halsen, øget sekret i de øvre luftveje, halsirritation, øvre luftvejhoste-syndrom
English: What Bortezomib SUN looks like and contents of the pack Bortezomib SUN 3.5 mg powder for solution for injection is a white to off-white powder or cake.
Danish: Bortezomib SUN 3.5 mg pulver til injektionsvæske, opløsning, er en hvid til gullig masse eller et hvidt til gulligt pulver.
English: Injection sites should be rotated for successive injections.
Danish: Der skal vælges et nyt injektionssted hver gang.
English: Melphalan and prednisone should both be given orally on days 1, 2, 3 and 4 of the first week of each Bortezomib SUN treatment cycle.
Danish: Der skal gå mindst 72 timer mellem 2 doser Bortezomib SUN. Melphalan og prednison bør begge gives oralt på dag 1, 2, 3 og 4 i den første uge af hver behandlingscyklus med Bortezomib SUN. Der gives ni behandlingscyklusser med denne kombinationsbehandling.
English: Uncommon Renal failure acute, Renal failure chronic*, Urinary tract infection*, Urinary tract signs and symptoms*, Haematuria*, Urinary retention, Micturition disorder*, Proteinuria, Azotaemia, Oliguria*, Pollakiuria
Danish: Akut nyresvigt, kronisk nyresvigt*, urinvejsinfektion*, urinvejssymptomer*, hæmaturi*, urinretention, miktionsforstyrrelser*, proteinuri, azotæmi, oliguri*, pollakisuri
English: Incidence Adverse reaction Common Pruritus*, Dermatitis*, Rash*
Danish: Hårsygdom* Almindelig Kløe*, dermatitis*, udslæt*
English: For additional information concerning pegylated liposomal doxorubicin, see the corresponding Summary of Product Characteristics.
Danish: Se det relevante produktresumé for yderligere oplysninger om pegyleret liposomal doxorubicin.
English: - In cycles 5 to 9, Bortezomib SUN is administered once weekly on days 1, 8, 22 and 29.
Danish: - I cyklus 5 til 9 gives Bortezomib SUN en gang om ugen på dag 1, 8, 22 og 29.
English: Common side effects (may affect up to 1 in 10 people) - shingles (localized including around the eyes or spread across the body) - herpes virus infections - bacterial and viral infections - respiratory infections, bronchitis, coughing with phlegm, flu like illness - fungal infections - hypersensitivity (allergic reaction) - inability to produce enough insulin or resistance to normal levels of insulin - fluid retention - difficulty or problems in sleeping - loss of consciousness - altered level of consciousness, confusion - feeling dizzy - increased heartbeat, high blood pressure, sweating - abnormal vision, blurred vision - heart failure, heart attack, chest pain, chest discomfort, increased or reduced heart rate - high or low blood pressure - sudden fall of blood pressure upon standing which may lead to fainting - shortness of breath with exercise - cough - hiccups - ringing in the ears, ear discomfort - bleeding from your bowels or stomach - heartburn - stomach pain, bloating - difficulty swallowing - infection or inflammation of the stomach and intestines - stomach pain - sore mouth or lip, throat pain - alteration of liver function - itching of skin - redness of skin - rash - muscle spasms - infection of the urinary tract - pain in limbs
Danish: Almindelige bivirkninger (kan forekomme hos op til 1 ud af 10 patienter) - helvedesild (lokaliseret, også omkring øjnene, eller spredt over kroppen) - herpesvirusinfektioner - bakterie- og virusinfektioner - luftvejsinfektioner, bronkitis, hoste med slim, influenzalignende sygdom - svampeinfektioner - overfølsomhed (allergisk reaktion) - manglende evne til at danne tilstrækkeligt insulin eller nedsat følsomhed (resistens) mod normale insulinniveauer - væskeansamlinger - besvær eller problemer med at sove - bevidsthedstab - ændret bevidsthedsniveau, forvirring - svimmelhed - hurtigere hjerteslag, højt blodtryk, svedtendens - unormalt syn, sløret syn - hjertesvigt, hjerteanfald, brystsmerter, ubehag i brystet, øget eller nedsat hjerterytme (puls) - højt eller lavt blodtryk - pludseligt fald i blodtrykket, når du rejser dig op, hvilket kan medføre, at du besvimer - stakåndethed ved fysisk udfoldelse - hoste - hikke - ringen for ørene, ubehag i ørerne - blødning fra tarm eller mave - halsbrand - mavesmerter, oppustethed - synkebesvær - infektion eller inflammation (betændelseslignende tilstand) i mave eller tarme - mavesmerter - øm mund eller ømme læber, halssmerter - ændringer i leverfunktion - hudkløe
English: Day 8
Danish: Dag 8 Pause
English: • Dosing Slide Rule
Danish: • Regnestok til brug ved dosering
English: Common Neuropathies*, Motor neuropathy*, Loss of consciousness (inc syncope), Encephalopathy*, Peripheral sensorimotor neuropathy, Dizziness*, Dysgeusia*, Autonomic neuropathy Uncommon Autonomic nervous system imbalance
Danish: synkope), encefalopati*, perifer sensomotorisk neuropati, svimmelhed*, dysgeusi*, autonom neuropati
English: A.
Danish: mdr.
English: In the same drug-drug interaction study assessing the effect of dexamethasone, a weaker CYP3A4 inducer, on the pharmacokinetics of bortezomib (injected intravenously), there was no significant effect on the pharmacokinetics of bortezomib based on data from 7 patients.
Danish: I det samme lægemiddelinteraktionsstudie blev virkningen af den svagere CYP3A4-induktor dexamethason på bortezomibs farmakokinetik (som intravenøs injektion) vurderet.
English: Death (inc sudden), Multi-organ failure, Injection site haemorrhage*, Hernia(inc hiatus)*, Impaired healing*,
Danish: pludselig død), multiorgansvigt, blødning fra injektionsstedet*, hernie (inkl.
English: Incidence Adverse reaction
Danish: Anafylaktisk reaktion
English: Then, Bortezomib SUN may be reinitiated at a dose reduced by one dose level (from 1.3 mg/m2 to 1 mg/m2, or from 1 mg/m2 to 0.7 mg/m2).
Danish: Derefter kan Bortezomib SUN-behandlingen genoptages ved en dosis, som er reduceret med ét dosisniveau (fra 1,3 mg/m2 til 1 mg/m2 eller fra 1 mg/m2 til 0,7 mg/m2).
English: Uncommon side effects (may affect up to 1 in 100 people) - heart failure, heart attack, chest pain, chest discomfort, increased or reduced heart rate - failing of your kidneys - inflammation of a vein, blood clots in your veins and lungs - problems with blood clotting - insufficient circulation - inflammation of the lining around your heart or fluid around your heart - infections including urinary tract infections, the flu, herpes virus infections, ear infection and cellulitis - bloody stools, or bleeding from mucosal membranes, e.g., mouth, vagina - cerebrovascular disorders - paralysis, seizures, falling, movement disorders, abnormal or change in, or reduced sensation
Danish: Ikke almindelige bivirkninger (kan forekomme hos op til 1 ud af 100 patienter) - hjertesvigt, hjerteanfald, brystsmerter, ubehag i brystet, øget eller nedsat hjerterytme - nyresvigt - betændelse i en vene, blodpropper i vener eller lunger - problemer med blodets størknen - nedsat cirkulation - betændelse i hjertesækken eller væske omkring hjertet - infektioner, herunder urinvejsinfektioner, influenza, herpesvirusinfektioner, øreinfektion og cellulitis - blod i afføringen eller blødning fra slimhinder, f.eks. i munden eller skeden - blodkarsygdomme, som rammer hjernen - lammelse, krampeanfald, fald, bevægelsesforstyrrelser, unormale eller forandringer i eller nedsatte sanser (føle-, høre-, smags- eller lugtesans), opmærksomhedsforstyrrelser, skælven,
English: - Haemoglobin ≥ 8 g/dl
Danish: - Hæmoglobin ≥ 8 g/dl (4,96 mmol/l).
English: Common side effects (may affect up to 1 in 10 people) - low blood pressure, sudden fall of blood pressure on standing which may lead to fainting - high blood pressure - reduced functioning of your kidneys - headache - general ill feeling, pain, vertigo, light-headedness, a feeling of weakness or loss of consciousness - shivering - infections, including pneumonia, respiratory infections, bronchitis, fungal infections, coughing with phlegm, flu like illness - shingles (localised including around the eyes or spread across the body) - chest pains or shortness of breath with exercise - different types of rash - itching of the skin, lumps on the skin or dry skin - facial blushing or tiny broken capillaries - redness of the skin - dehydration - heartburn, bloating, belching, wind, stomach pain, bleeding from your bowels or stomach - alteration of liver functioning - a sore mouth or lip, dry mouth, mouth ulcers or throat pain - weight loss, loss of taste - muscle cramps, muscle spasms, muscle weakness, pain in your limbs - blurred vision - infection of the outermost layer of the eye and the inner surface of the eyelids (conjunctivitis) - nose bleeds - difficulty or problems in sleeping, sweating, anxiety, mood swings, depressed mood,
Danish: Almindelige bivirkninger (kan forekomme hos op til 1 ud af 10 patienter) - lavt blodtryk, pludseligt blodtryksfald i stående stilling, som kan medføre besvimelse - højt blodtryk - nedsat nyrefunktion - hovedpine - generel følelse af at være syg, smerter, svimmelhed, ør i hovedet, en følelse af afkræftelse eller bevidsthedstab - kulderystelser - infektioner, inklusive lungebetændelse, luftvejsinfektioner, bronkitis, svampeinfektioner, hoste med slim, influenzalignende sygdom - helvedesild (lokaliseret, også omkring øjnene eller spredt over kroppen) - brystsmerter eller stakåndehed ved fysisk udfoldelse - forskellige typer udslæt - hudkløe, buler i huden eller tør hud - ansigtsrødmen eller bittesmå sprængte blodkar - rødmen af huden - dehydrering - halsbrand, oppustethed, ræben, luft i tarmene, mavesmerter, blødning fra mave eller tarm - ændringer i leverfunktion - øm mund eller ømme læber, tør mund, sår i munden eller halssmerter - vægttab, tab af smagssans - muskelkramper, muskelspasmer, muskelsvaghed, smerter i dine lemmer - sløret syn - infektion i øjets yderste lag og i indersiden af øjenlåget (conjunctivitis) - næseblod
English: Bortezomib SUN is administered via intravenous or subcutaneous injection at the recommended dose of 1.3 mg/m2 body surface area twice weekly for two weeks on days 1, 4, 8, and 11 in a 21-day treatment cycle.
Danish: Bortezomib SUN administreres som intravenøs eller subkutan injektion i den anbefalede dosis på 1,3 mg/m2 legemsoverfladeareal to gange om ugen i to uger på dag 1, 4, 8 og 11 i en 21-dages behandlingscyklus.
English: The most commonly reported adverse reactions during treatment with bortezomib are nausea, diarrhoea, constipation, vomiting, fatigue, pyrexia, thrombocytopenia, anaemia, neutropenia, peripheral neuropathy (including sensory), headache, paraesthesia, decreased appetite, dyspnoea, rash, herpes zoster and myalgia.
Danish: trombocytopeni, anæmi, neutropeni, perifer neuropati (inklusive sensorisk neuropati), hovedpine, paræstesier, nedsat appetit, dyspnø, udslæt, herpes zoster og myalgi.
English: Bzmb=bortezomib; Dex=dexamethasone CR=Complete Response; nCR=near Complete response PR=Partial Response; MR=Minimal response
Danish: CR = komplet respons; nCR = næsten komplet respons.
English: LIST OF EXCIPIENTS Excipient: mannitol (E421)
Danish: LISTE OVER HJÆLPESTOFFER Mannitol (E 421)
English: - Injection sites should be rotated for successive injections.
Danish: - Der skal vælges et nyt injektionssted hver gang.
English: Common Rash*, Pruritus*, Erythema, Dry skin Uncommon Erythema multiforme, Urticaria, Acute febrile neutrophilic dermatosis, Toxic skin eruption, Toxic epidermal necrolysis#, Stevens-Johnson syndrome#, Dermatitis*, Hair disorder*, Petechiae, Ecchymosis, Skin lesion, Purpura, Skin mass*, Psoriasis, Hyperhidrosis, Night sweats, Decubitus ulcer#, Acne*, Blister*, Pigmentation disorder*
Danish: Erythema multiforme, urticaria, akut febril neutrofil dermatose, toksisk huderuption, toksisk epidermal nekrolyse#, Stevens-Johnsons syndrom#, dermatitis*, hårsygdom*, petekkier, ekkymose, hudlæsion, purpura, udfyldning i huden*, psoriasis, hyperhidrose, nattesved, decubitus#, akne*, blister*, fejlpigmentering* Sjælden Hudreaktion, Jessners benigne lymfocyt-infiltration, palmoplantar erytrodysæstesi (hånd-fod-syndrom), subkutan blødning, livedo reticularis, fortykkelse af huden, papler, lysfølsomhedsreaktion, seborré, koldsved, uspecificeret hudsygdom, erytrose, hudsår, neglesygdom
English: When Bortezomib SUN is given in combination with other medicinal products, the Summary of Product Characteristics of these other medicinal products must be consulted prior to initiation of treatment with Bortezomib SUN.
Danish: Når Bortezomib SUN gives i kombination med andre lægemidler, bør produktresuméerne for disse lægemidler kontrolleres før initiering af behandling med Bortezomib SUN. Ved anvendelse af thalidomid skal man være særligt opmærksom på behovet for graviditetsprøver og prævention (se pkt.
English: You may also be given Bortezomib SUN together with the medicines pegylated liposomal doxorubicin or dexamethasone: - When Bortezomib SUN is given together with pegylated liposomal doxorubicin, you will receive Bortezomib SUN intravenously or subcutaneously as a 21-day treatment cycle.
Danish: Du kan ligeledes få Bortezomib SUN sammen med lægemidlerne pegyleret liposomal doxorubicin eller dexamethason.
English: Fluid overload, Hypochloraemia*, Hypovolaemia, Hyperchloraemia *, Hyperphosphataemia*, Metabolic disorder, Vitamin B complex deficiency, Vitamin B12 deficiency, Gout, Increased appetite, Alcohol intolerance
Danish: Tumorlysesyndrom, manglende trivsel*, hypomagnesiæmi*, hypofosfatæmi*, hyperkaliæmi*, hyperkalcæmi*, hypernatriæmi*, unormal urinsyre*, diabetes mellitus*, væskeretention Sjælden Hypermagnesiæmi*, acidose, forstyrrelser i elektrolytbalancen*, væskeophobning, hypokloræmi*, hypovolæmi, hyperkloræmi*, hyperfosfatæmi*, stofskiftesygdom, B-vitaminmangel, B12vitaminmangel, artritis urica, øget appetit, alkoholintolerans
English: However, the chemical and physical in-use stability has been demonstrated for 8 hours at 25°C stored in the original vial and/or a syringe.
Danish: Den færdigblandede injektionsvæske er stabil i 8 timer ved 25 ºC ved opbevaring i det originale hætteglas og/eller en sprøjte.
English: Bortezomib SUN therapy should be withheld
Danish: Bortezomib SUN-behandling skal tilbageholdes.
English: Combination therapy with pegylated liposomal doxorubicin Bortezomib SUN is administered via intravenous or subcutaneous injection at the recommended dose of 1.3 mg/m2 body surface area twice weekly for two weeks on days 1, 4, 8, and 11 in a 21-day treatment cycle.
Danish: Kombinationsbehandling med pegyleret liposomal doxorubicin Bortezomib SUN administreres som intravenøs eller subkutan injektion i den anbefalede dosis på 1,3 mg/m2 legemsoverfladeareal to gange om ugen i to uger på dag 1, 4, 8 og 11 i en 21-dages behandlingscyklus.
English: Bladder irritation
Danish: Sjælden Blæreirritation
English: Common Gastrointestinal haemorrhage (inc mucosal)*, Dyspepsia, Stomatitis*, Abdominal distension, Oropharyngeal pain*, Abdominal pain (inc gastrointestinal and splenic pain)*, Oral disorder*, Flatulence
Danish: fra slimhinde)*, abdominal distension, dyspepsi, orofaryngeale smerter*, gastritis*, mundsår*, abdominalt ubehag, dysfagi, gastrointestinal inflammation*, abdominalsmerter (inkl.
English: What Bortezomib SUN is and what it is used for What you need to know before you are given Bortezomib SUN How to use Bortezomib SUN
Danish: Det skal du vide, før du begynder at bruge Bortezomib SUN Sådan skal du bruge Bortezomib SUN Bivirkninger
English: Decreased appetite Common Hypokalaemia*, Blood glucose abnormal*, Hyponatraemia*, Diabetes mellitus*, Fluid retention Uncommon Tumour lysis syndrome
Danish: Almindelig Hypokaliæmi*, unormal blodglucose*, hyponatriæmi*, diabetes mellitus*, væskeretention
English: ≥ 2 prior lines
Danish: ≥ Grad 2-PN ≥ Grad 3-PN
English: Dexamethasone 20 mg is given orally on days 1, 2, 4, 5, 8, 9, 11, and 12, of the Bortezomib SUN 21-day treatment cycle.
Danish: Dexamethason administreres oralt ved en dosis på 20 mg på dag 1, 2, 4, 5, 8, 9, 11 og 12 i Bortezomib SUN-behandlingscyklussen.
English: Common Cardiac fibrillation (inc atrial), Arrhythmia*, Cardiac failure (inc left and right ventricular)*, Myocardial ischaemia, Ventricular dysfunction* Uncommon Cardiovascular disorder (inc cardiogenic shock)
Danish: perikardieeffusion)*, kardiomyopati*, ventrikeldysfunktion*, bradykardi Sjælden Atrieflagren, myokardieinfarkt*, atrioventrikulært blok*, kardiovaskulær sygdom (inkl.
English: Pancreatitis acute, Peritonitis*, Tongue oedema*, Ascites, Oesophagitis, Cheilitis, Faecal incontinence, Anal sphincter atony, Faecaloma*, Gastrointestinal ulceration and perforation*, Gingival hypertrophy, Megacolon, Rectal discharge, Oropharyngeal blistering*, Lip pain, Periodontitis, Anal fissure, Change of bowel habit, Proctalgia, Abnormal faeces
Danish: Sjælden Akut pankreatitis, peritonitis*, tungeødem*, ascites, øsofagitis, læbebetændelse, fækal inkontinens, analsfinkteratoni, fækalom*, gastrointestinal ulcus og perforation*, gingival hypertrofi, megacolon, rektalt udflåd, blisterdannelse i hals og svælg*, læbesmerter, parodontitis, analfissur, forandringer i peristaltikken, proktalgi, anormal fæces
English: Combination therapy with dexamethasone and thalidomide Bortezomib SUN is administered via intravenous or subcutaneous injection at the recommended dose of 1.3 mg/m2 body surface area twice weekly for two weeks on days 1, 4, 8, and 11 in a 28-day treatment cycle.
Danish: Kombinationsbehandling med dexamethason og thalidomid Bortezomib SUN administreres som intravenøs eller subkutan injektion i den anbefalede dosis på 1,3 mg/m2 legemsoverfladeareal to gange om ugen i to uger på dag 1, 4, 8 og 11 i en 21-dages behandlingscyklus.
English: Hepatic failure, Hepatomegaly, Budd-Chiari syndrome, Cytomegalovirus hepatitis, Hepatic haemorrhage, Cholelithiasis
Danish: leversygdom), hepatitis*, kolestase Sjælden Leversvigt, hepatomegali, Budd-Chiaris syndrom, cytomegalovirus-hepatitis, leverblødning, kolelitiasis Hud og subkutane væv Almindelig Udslæt*, kløe*, erytem, tør hud Ikke almindelig
English: Patients with renal impairment should be monitored closely (see sections 4.2 and 5.2).
Danish: Patienter med nedsat nyrefunktion skal monitoreres nøje (se pkt.
English: Common Mood disorders and disturbances*, Anxiety disorder*, Sleep disorders and disturbances* Uncommon Mental disorder*, Hallucination*, Psychotic disorder*, Confusion*, Restlessness
Danish: Sindslidelser*, hallucinationer*, psykose*, konfusion*, rastløshed
English: Incidence of PN (%) All GradePN ≥ Grade 2 PN ≥ Grade 3 PN Discontinuation due to PN (%)
Danish: Forekomst af PN (%) PN i alle grader
English: Common Dyspnoea*, Cough*, Hiccups Uncommon Acute respiratory distress syndrome, Pulmonary embolism, Pneumonitis, Pulmonary hypertension, Pulmonary oedema (inc acute)
Danish: Akut respiratory distress syndrome, lungeemboli, pneumonitis, pulmonal hypertension, lungeødem (inkl.
English: Cardiac disorders
Danish: Kardiovaskulær sygdom (inkl.
English: Common Motor neuropathy*, Loss of consciousness (inc syncope), Dizziness*, Dysgeusia*, Lethargy, Headache* Uncommon Tremor, Peripheral sensorimotor neuropathy, Dyskinesia*, Cerebellar coordination and balance disturbances*, Memory loss (exc dementia)*, Encephalopathy*, Posterior Reversible Encephalopathy Syndrome#, Neurotoxicity, Seizure disorders*, Post herpetic neuralgia, Speech disorder*, Restless legs syndrome, Migraine, Sciatica, Disturbance in attention, Reflexes abnormal*, Parosmia
Danish: demens)*, encefalopati*, posteriort reversibelt encefalopatisk syndrom#, neurotoksicitet, epileptiske anfald*, postherpetisk neuralgi, taleforstyrrelser*, restless legs-syndrom, migræne, skiatika, opmærksomhedsforstyrrelser, abnorme reflekser*, parosmi
English: (1.3 mg/m2)
Danish: Uge Bzmb (1,3 mg/m2)
English: breathing that becomes shallow, difficult or stops, wheezing - blood clots in your lungs - yellow discoloration of the eyes and skin (jaundice) - lump in the eyelid (chalazion), red and swollen eyelids.
Danish: Nogle af disse sygdomme indebærer vejrtrækningsbesvær, kortåndethed, kortåndethed uden fysiske udfoldelser, overfladisk eller besværet vejrtrækning eller stop i vejrtrækningen, hvæsende vejrtrækning - blodpropper i lungerne - gulfarvning af øjne og hud (gulsot) - haglkorn (en knude i øjenlåget), røde og hævede øjenlåg.
English: Common Renal impairment*
Danish: clostridium difficile)*
English: Common Hypersensitivity* Uncommon Anaphylactic reaction
Danish: Almindelig Overfølsomhed* Ikke almindelig
English: Common Eye swelling*, Vision abnormal*, Conjunctivitis* Uncommon Eye haemorrhage*, Eyelid infection*, Chalazion#, Blepharitis#, Eye inflammation*, Diplopia, Dry eye*, Eye irritation*, Eye pain, Lacrimation increased, Eye discharge
Danish: Øjenblødning*, øjenlågsinfektion*, chalazion#, blefaritis#, øjeninflammation*, diplopi, øjentørhed*, øjenirritation*, øjensmerter, øget tåreflåd, øjenflåd Sjælden Læsion i cornea*, eksoftalmi, retinitis, skotom, uspecificeret øjensygdom (inkl.
English: NAME OF THE MEDICINAL PRODUCT Bortezomib SUN 3.5 mg powder for solution for injection bortezomib
Danish: Bortezomib SUN 3,5 mg pulver til injektionsvæske, opløsning bortezomib